Logo image of MED

MEDIFAST INC (MED) Stock Analyst Ratings

NYSE:MED - New York Stock Exchange, Inc. - US58470H1014 - Common Stock - Currency: USD

14.73  +0.4 (+2.79%)

After market: 14.7 -0.03 (-0.2%)

Buy % Consensus

47

ChartMill assigns a Buy % Consensus number of 47% to MED. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 16.83. This target is 14.26% above the current price.
MED was analyzed by 9 analysts. The buy percentage consensus is at 47. So analysts seem to be rather neutral about MED.
In the previous month the buy percentage consensus was at a similar level.
MED was analyzed by 9 analysts. More opinions would make the average more meaningful.
MED Historical Analyst RatingsMED Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -98 -89 -80 -71 -62 -53 -44 -35 -26 -17 -8 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 14.7316.1616.8316.8317.85 - 9.71% 14.26% 14.26% 21.18%
MED Current Analyst RatingMED Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-02-19 DA Davidson Maintains Neutral -> Neutral
2024-11-05 DA Davidson Upgrade Underperform -> Neutral
2024-07-22 DA Davidson Maintains Underperform -> Underperform
2024-06-05 DA Davidson Downgrade Neutral -> Underperform
2024-04-30 DA Davidson Maintains Neutral -> Neutral
2024-02-21 DA Davidson Maintains Neutral -> Neutral
2023-10-13 Stephens & Co. Initiate Equal-Weight
2023-08-08 DA Davidson Maintains Neutral -> Neutral
2023-07-31 DA Davidson Maintains Neutral -> Neutral
2023-05-02 DA Davidson Maintains Neutral
2023-02-22 DA Davidson Maintains Neutral
2022-11-04 DA Davidson Downgrade Buy -> Neutral
2022-08-04 DA Davidson Maintains Buy
2022-08-04 Jefferies Downgrade Buy -> Hold
2022-06-02 DA Davidson Maintains Buy
2022-02-24 DA Davidson Maintains Buy
2021-11-08 DA Davidson Maintains Buy
2021-05-05 DA Davidson Maintains Buy
2021-02-26 DA Davidson Maintains Buy